SATB2 and colorectal carcinoma: In addition, univariate regression analyses of our cohorts demonstrated that SATB2-AS1 expression was an independent predictor for predicting the overall survival of CRC patients (Hazard ratio [HR] = 0.28, 95% confidence interval [CI] = 0.10–0.78, P = 0.015, Additional file 3: Figure S1g).